Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
CHF: full-pipeline trial registry
2 of 6 indexed CHF trials are currently recruiting.
Corpus placement: #2,866 of 28,707 conditions by registered trial count.
6 US clinical trials · 2 currently recruiting · #2,866 of 28,707 conditions by registered trial count
CHF: 6 US clinical trials tracked, 2 recruiting.
CHF is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Nile Therapeutics, running 1 of these trials.
Enrollment posture brief
Registry condition chf
OPEN 2 | RECR 33% | LATE 1 | EARLY 1 | RANK #2866 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
CHF lists 2 open slots (33% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for CHF on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
CHF is recruiting below its size-band peers.
2 of 6 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates CHF research.
Nile Therapeutics accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.
-
Typical CHF enrolment sits around 135 participants.
Median target enrolment is 135 among the 6 trials that report a genuine target (sentinel values excluded). 3 of those (50%) plan for fewer than 100 participants.
-
CHF splits between interventional and observational designs.
4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
6 total, page 1 of 1
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
BioVentrix
NCT06813820
Salivary Extracellular Vesicle Associated lncRNAs in Heart Failure (SEAL-HF)
Massachusetts General Hospital
NCT06169540
Biomarkers for Human Heart Failure
Mayo Clinic
NCT03905252
A Technology Assisted Care Transition Intervention for Veterans With CHF or COPD
VA Office of Research and Development
NCT02632552
PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients
Nile Therapeutics
NCT01316432
Extracorporeal Ultrafiltration (UF) vs. Usual and Customary Care for Patients With Severe Heart Failure (HF)
NxStage Medical
NCT00288587
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on CHF records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on CHF trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this CHF page
6 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 CHF trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Nile Therapeutics sponsors the most CHF trials on record, review their full trial history before evaluating a specific study. See Nile Therapeutics's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This CHF condition card totals 6 registered trials; most-linked intervention IV loop diuretic; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.